Search Results - "S. Kaltoft, Margit"

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries by Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy M E, Dieuzeide, Guillermo, Eriksen, Kirsten T, Hong, Tianpei, Kaltoft, Margit S, Lengyel, Csaba, Rhee, Nicolai A, Russo, Giuseppina T, Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio

“…There is a paucity of global data on cardiovascular disease (CVD) prevalence in people with type 2 diabetes (T2D). The primary objective of the CAPTURE study…”
Get full text

Between-Strain Competition in Acquisition and Clearance of Pneumococcal Carriage—Epidemiologic Evidence From a Longitudinal Study of Day-Care Children by Auranen, Kari, Mehtälä, Juha, Tanskanen, Antti, S. Kaltoft, Margit

“…The state of pneumococcal carriage—that is, pneumococcal colonization in the nasopharynx of healthy persons—represents a reservoir for the spread of…”
Get full text

Genetic Relatedness of the Streptococcus pneumoniae Capsular Biosynthetic Loci by MAVROIDI, Angeliki, AANENSEN, David M, GODOY, Daniel, SKOVSTED, Ian C, KALTOFT, Margit S, REEVES, Peter R, BENTLEY, Stephen D, SPRATT, Brian G

“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes by Kaltoft, Margit S., Skov Sørensen, Uffe B., Slotved, Hans-Christian, Konradsen, Helle Bossen

“…In this paper, a simplified method for detection of pneumococcal carriage and for revealing the presence of several serotypes in a nasopharyngeal sample is…”
Get full text

Bordetella pertussis Strains Circulating in Europe in 1999 to 2004 as Determined by Pulsed-Field Gel Electrophoresis by Hallander, Hans, Advani, Abdolreza, Riffelmann, Marion, von König, Carl H.W, Caro, Valerie, Guiso, Nicole, Mooi, Frits R, Gzyl, Anna, Kaltoft, Margit S, Fry, Norman K, Mertsola, Jussi, He, Qiushui

“…Clinical isolates of Bordetella pertussis collected during the year 2004 (n = 153) in eight European countries, Denmark, Finland, France, Germany, The…”
Get full text

Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies by Rosenstock, Julio, Cariou, Bertrand, Eliasson, Johanna, Frappin, Guillaume, Kaltoft, Margit S., Montanya, Eduard, Knop, Filip K.

“…Aim To assess how long participants with type 2 diabetes spent with HbA1c less than 7.0% and how likely they were to maintain this target with oral semaglutide…”
Get full text

Perinatal and Crowding-Related Risk Factors for Invasive Pneumococcal Disease in Infants and Young Children: A Population-Based Case-Control Study by Hjuler, Thomas, Wohlfahrt, Jan, Simonsen, Jacob, Kaltoft, Margit S., Koch, Anders, Kamper-Jørgensen, Mads, Biggar, Robert J., Melbye, Mads

“…Background. Denmark's systems of registry-based data offer a unique opportunity to examine, on a population basis, risk factors for invasive pneumococcal…”
Get full text

Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i by Blonde, Lawrence, Fainberg, Udi, Kaltoft, Margit S., Mosenzon, Ofri, Ramesh, Chethana, Rea, Rosangela

“…Aims The LIRA‐ADD2SGLT2i trial demonstrated that liraglutide + sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) ± metformin significantly improved glycaemic…”
Get full text

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial by Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia‐Hernandez, Pedro A., Jain, Sunil M., Kaltoft, Margit S., Mosenzon, Ofri, Nafach, Jalal, Palle, Mads Sundby, Rea, Rosangela

“…Aim To compare the effect of liraglutide or placebo added on to sodium‐glucose co‐transporter‐2 inhibitor (SGLT2i) ± metformin on glycaemic control in patients…”
Get full text

Validation of a Multiplex Pneumococcal Serotyping Assay with Clinical Samples by Lin, Jisheng, Kaltoft, Margit S, Brandao, Angela P, Echaniz-Aviles, Gabriela, Brandileone, M. Cristina C, Hollingshead, Susan K, Benjamin, William H, Nahm, Moon H

“…We have recently developed a rapid pneumococcal serotyping method called "multibead assay" (J. Yu et al., J. Clin. Microbiol. 43:156-162, 2005) based on a…”
Get full text

Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis by Wilke, Thomas, Mueller, Sabrina, Fuchs, Andreas, Kaltoft, Margit S., Kipper, Stefan, Cel, Malgorzata

“…Introduction Liraglutide is a glucagon-like peptide-1 analogue used to treat type 2 diabetes mellitus (T2DM). To date, limited long-term data (> 2 years) exist…”
Get full text

Competition Between Streptococcus Pneumoniae Strains: Implications for Vaccine-Induced Replacement in Colonization and Disease by Mehtälä, Juha, Antonio, Martin, Kaltoft, Margit S., O'Brien, Katherine L., Auranen, Kari

“…Background: Vaccine-induced replacement by nonvaccine serotypes in pneumococcal colonization and disease poses a threat to the long-term effectiveness of…”
Get full text

Emergence of Invasive Serotype VIII Group B Streptococcal Infections in Denmark by EKELUND, Kim, SLOTVED, Hans-Christian, NIELSEN, Hans Ulrik, KALTOFT, Margit S, KONRADSEN, Helle B

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Is there an association between liraglutide use and female breast cancer in a real-world setting? by Funch, Donnie, Mortimer, Kathleen, Li, Ling, Norman, Heather, Major-Pedersen, Atheline, Olsen, Anne Helene, Kaltoft, Margit S, Dore, David D

“…Liraglutide is a human glucagon-like peptide-1 receptor agonist approved for treatment of adults with type 2 diabetes mellitus at a maximum dose of 1.8 mg/day…”
Get full text

Switching from Sitagliptin to Liraglutide in Subjects with Type 2 Diabetes (T2D): Analysis of Composite Endpoints from the LIRA-SWITCH Randomized Trial by Boras, Damir, Bailey, Timothy S, Takács, Róbert, Tinahones, Francisco J, Rao, Paturi V, Tsoukas, George M, Christensen, Sidsel B, Kaltoft, Margit S, Maislos, Maximo

Get full text

A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination by Harboe, Zitta B, Slotved, Hans-Christian, Konradsen, Helle B, Kaltoft, Margit S

“…We present data on pneumococcal carriage before the introduction of the heptavalent-pneumococcal conjugated vaccine (PCV7) in Denmark. In the pre-PCV7 period,…”
Get full text

A Comparison of Antibiotic Use in Children Between Canada and Denmark by Marra, Fawziah, Monnet, Dominique L, Patrick, David M, Chong, Mei, Brandt, Christian T, Winters, Meghan, Kaltoft, Margit S, Tyrrell, Gregory J, Lovgren, Marguerite, Bowie, William R

“…Background: High rates of antibiotic prescribing in children lead to antibiotic resistance in the community. Surveillance on utilization rates and comparisons…”
Get full text

Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine by Winther, Thilde N, Kristensen, Tim D, Kaltoft, Margit S, Konradsen, Helle B, Knudsen, Jenny D, Høgh, Birthe

“…Aim: The aim of this study was to document the epidemiology, microbiology and outcome of invasive pneumococcal disease (IPD) among children <16 years with…”
Get full text

Community outbreak of perianal group A streptococcal infection in Denmark by PETERSEN, JESPER P, KALTOFT, MARGIT S, MISFELDT, JENS C, SCHUMACHER, HELGA, SCHØNHEYDER, HENRIK C

“…BACKGROUND.Perianal group A streptococcal infection (PASI) occurs primarily in children. There is limited information on the incidence, transmission and…”
Get full text

Greater time spent with HbA1cless than7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies by Rosenstock, Julio, Cariou, Bertrand, Eliasson, Johanna, Frappin, Guillaume, Kaltoft, Margit S, Montanya, Eduard, Knop, Filip K

“…AimTo assess how long participants with type 2 diabetes spent with HbA1c less than 7.0% and how likely they were to maintain this target with oral semaglutide…”
Get full text